Evidence map›Paper›PMID 40321607›Full record

ArticleFood science & nutrition2025

Impact of Probiotics Administration on the VEGF, Adiponectin, and Glycolipid Metabolism, in Prediabetic Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Mehrdad Sarabi, Ashkan Torshizian, Zahra Mazloum Khorasani, Abdollah Firoozi, Hassan Mehrad Majd, Nastaran Khoshhal, Nikoo Saeidi, Mina AkbariRad

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mehrdad SarabiStudent Research Committee, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Ashkan TorshizianMetabolic Syndrome Research Center Mashhad University of Medical Sciences Mashhad Iran.ORCID https://orcid.org/0000-0002-5798-7737
Zahra Mazloum KhorasaniDepartment of Endocrinology, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Abdollah FirooziMashhad University of Medical Sciences Mashhad Iran.
Hassan Mehrad MajdMolecular Medicine, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Nastaran KhoshhalStudent Research Committee, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Nikoo SaeidiStudent Research Committee Islamic Azad University Mashhad Iran.
Mina AkbariRadDepartment of Internal Medicine, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.ORCID https://orcid.org/0000-0002-1071-7983

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is debated that probiotics can improve glycolipid metabolism and slow the progression of prediabetes to diabetes mellitus. This study aimed to evaluate the effect of probiotics on lipid profile, glucose homeostasis, serum level of resistin, adiponectin, and vascular endothelial growth factor (VEGF) in prediabetic patients. This double-blind, randomized, placebo-controlled clinical trial was conducted on prediabetic patients in the Endocrinology clinic of Ghaem Hospital. Patients were randomly divided into two groups: the probiotics group was prescribed a daily 500-mg capsule of probiotics (10

Indexed as

adiponectinprediabetesprobioticresistinVEGF

Identifiers

PMID40321607
PMCPMC12045928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.